Preoperative Bleeding Risk Assessment: Why Testing Matters for Surgical Safety

Why Screen for Bleeding Disorders?

Undiagnosed coagulopathies convert routine procedures into hemorrhagic crises. Systematic preoperative assessment identifies at-risk patients, guides perioperative management, and reduces preventable morbidity.

Who Needs Testing

All patients undergoing procedures with significant bleeding risk (not just tooth extraction).
High-yield clinical indicators:
- Personal history: easy bruising, epistaxis, menorrhagia, postpartum hemorrhage, prolonged bleeding after dental work/surgery/circumcision.
- Family history: bleeding disorder, consanguinity.
- Medications: anticoagulants, antiplatelets, NSAIDs, fish oil, vitamin E, DOACs, herbal supplements (ginkgo, garlic, ginseng).
- Medical conditions: liver disease, renal failure, hematologic malignancy, autoimmune disease, vitamin K deficiency.

Standard Screening Panel

When to Expand Testing

Abnormal screen + clinical suspicion → mixing studies, factor assays, vWD panel (vWF:Ag, vWF:RCo, FVIII), platelet function analyzer (PFA-100/200), TEG/ROTEM.
High-risk surgery (cardiac, neuro, spine, major vascular, liver, orthopedic oncology) → baseline TEG/ROTEM increasingly standard.

Perioperative Management Based on Results

vWD Type 1: DDAVP 0.3 mcg/kg IV/IN pre-op; avoid if Type 2B/3.
Hemophilia A/B: Factor concentrate to target level (80–100% major surgery); hematology co-management.
Platelet Dysfunction: DDAVP (uremia, aspirin effect); platelet transfusion if severe/refractory.
Anticoagulated Patients: Bridging protocol per ACCP/ASH guidelines (CHA2DS2-VASc, HAS-BLED, thrombosis risk).

Informed Consent & Shared Decision-Making

Discuss: baseline bleeding risk, procedure-specific risk, how testing changes plan, transfusion thresholds, alternatives. Document.

Emergency Preparedness

Type & screen / crossmatch available.
Massive transfusion protocol (MTP) activation criteria known.
Factor concentrates, PCC, cryoprecipitate, platelets accessible.
Cell salvage (if appropriate).

Preoperative hemostasis screening is not ritual — it is anticipatory safety engineering. A 5-minute history and $50 of labs can prevent a $500,000 complication.

Fillings - Related Articles

Test	Detects	Limitation
CBC + Platelet Count	Thrombocytopenia, anemia	Does not assess function
PT / INR	Extrinsic pathway (VII, X, V, II, fibrinogen); warfarin effect	Insensitive to factor VIII/IX/XI/XII deficiency
aPTT	Intrinsic pathway (VIII, IX, XI, XII); heparin effect	Insensitive to mild factor deficiencies, vWD
Fibrinogen	Hypofibrinogenemia, dysfibrinogenemia	Acute phase reactant (falsely elevated)